Combined Management in ALI ( Image Guided Thrombectomy With Open Transfemoral Access )
Combined Treatment ( Image Guided Thrombectomy and Endovascular Therapy With Open Femoral Access ) for Acute Limb Ischemia
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Acute limb ischemia (ALI) is a sudden decrease in limb perfusion due to either an embolic or a thrombotic vascular occlusion, defined as the presence of symptoms within two weeks of onset. The profound ischemia represents an emergency in which delayed treatment results in limb loss and, potentially, death. Therefore, timely diagnosis and proper treatments for ALI are important. Both surgical thrombectomy and endovascular treatment have benefits and drawbacks. Surgical thrombectomy using Fogarty embolectomy catheter has been the standard therapy because it is rapid and effective in cases of embolic ALI. However, blind surgical thrombectomy can result in poor revascularization or unexpected vascular injury in the presence of underlying arterial atherosclerosis or in the presence of subacute and chronic thrombi. In addition, thrombosis of runoff vessels is difficult to remove. Endovascular management using catheter-directed thrombolysis (CDT) has emerged as an alternative to surgery. It is less invasive, and does not directly damage the vascular endothelium with the capacity to clear thrombus in the small vessels. However, long treatment duration may worsen the clinical situation. Besides, a thrombus of more than two weeks does not respond well to the thrombolysis, and it is difficult to determine the exact stage of thrombus according to the clinical history. These problems may be minimized by combined treatment, which includes surgical thrombectomy and endovascular treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedNovember 13, 2020
November 1, 2020
1 year
September 27, 2020
November 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
limb salvage
Technical success rates is defined as patency of the treated vessel segment with less than 20 % residual stenosis , without dissection and restoration of in line flow to foot , weight and height of the pt will be combined to report BMI kg/m\^2
immediately post operative
Study Arms (1)
acute lower limb ischemia patients
OTHERpatients with no palpable pulsations or audible signals in the lower limb
Interventions
open femoral access with fogarty catheter then PTA with balloon and possible stenting if needed
Eligibility Criteria
You may qualify if:
- Patients with acute onset of lower limb pain with various degrees of movement compromise.
- History of intermittent claudication with a sudden worsening of claudication and pain at rest for less than one month.
- Patients with Duplex or MSCT angiography of the lower limbs showing embolic events on healthy vessels or thrombosis of diseased vessels with or without collateralization.
- Thrombus in a poor location that is difficult to be removed by surgical thrombectomy alone.
- Acute lower limb ischemia due to acute arterial graft occlusion
You may not qualify if:
- \- Medically compromised patients, not fit for the intervention.
- Patients with critical chronic limb ischemia (grade III, IV).
- Patients with known vasculitis or lab investigations suggesting vasculitis before treating the cause.
- Patients who refused the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 Sep;26(3):517-38. doi: 10.1016/s0741-5214(97)70045-4.
PMID: 9308598BACKGROUNDKashyap VS, Gilani R, Bena JF, Bannazadeh M, Sarac TP. Endovascular therapy for acute limb ischemia. J Vasc Surg. 2011 Feb;53(2):340-6. doi: 10.1016/j.jvs.2010.08.064. Epub 2010 Nov 3.
PMID: 21050699BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident physician at vascular surgery department ، Assiut University
Study Record Dates
First Submitted
September 27, 2020
First Posted
November 10, 2020
Study Start
December 1, 2020
Primary Completion
December 1, 2021
Study Completion
December 31, 2021
Last Updated
November 13, 2020
Record last verified: 2020-11